Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
6.82
-0.06 (-0.87%)
At close: May 12, 2025, 4:00 PM
6.85
+0.03 (0.44%)
After-hours: May 12, 2025, 6:33 PM EDT
Kamada Market Cap
Kamada has a market cap or net worth of $387.67 million as of May 12, 2025. Its market cap has increased by 30.22% in one year.
Market Cap
387.67M
Enterprise Value
319.00M
1-Year Change
30.22%
Ranking
Category
Stock Price
$6.82
Market Cap Chart
Since May 31, 2013, Kamada's market cap has increased from $346.50M to $387.67M, an increase of 11.88%. That is a compound annual growth rate of 0.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 395.60M | 13.00% |
| Dec 31, 2024 | 350.10M | 27.59% |
| Dec 29, 2023 | 274.40M | 52.78% |
| Dec 30, 2022 | 179.60M | -38.99% |
| Dec 31, 2021 | 294.40M | 12.58% |
| Dec 31, 2020 | 261.50M | -4.98% |
| Dec 31, 2019 | 275.20M | 36.71% |
| Dec 31, 2018 | 201.30M | 16.29% |
| Dec 29, 2017 | 173.10M | -12.80% |
| Dec 30, 2016 | 198.50M | 33.04% |
| Dec 31, 2015 | 149.20M | 9.22% |
| Dec 31, 2014 | 136.60M | -73.22% |
| Dec 31, 2013 | 510.10M | 47.22% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |